Animal models of toxicology testing: the role of pigs

被引:92
|
作者
Helke, Kristi L. [1 ]
Swindle, Marvin Michael [1 ]
机构
[1] Med Univ S Carolina, Charleston, SC 29425 USA
关键词
cytochrome P450; drug metabolism; kidney; liver; pig; skin; toxicology; DRUG-METABOLIZING ACTIVITIES; SUS-SCROFA-DOMESTICA; P-GLYCOPROTEIN MDR1; IN-VITRO METABOLISM; LIVER-MICROSOMES; CYTOCHROME-P450; ENZYMES; MINIATURE PIGS; UDP-GLUCURONOSYLTRANSFERASES; XENOBIOTIC METABOLISM; ORAL BIOAVAILABILITY;
D O I
10.1517/17425255.2013.739607
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction: In regulatory toxicological testing, both a rodent and non-rodent species are required. Historically, dogs and non-human primates (NHP) have been the species of choice of the non-rodent portion of testing. The pig is an appropriate option for these tests based on metabolic pathways utilized in xenobiotic biotransformation. Areas covered: This review focuses on the Phase I and Phase II biotransformation pathways in humans and pigs and highlights the similarities and differences of these models. This is a growing field and references are sparse. Numerous breeds of pigs are discussed along with specific breed differences in these enzymes that are known. While much available data are presented, it is grossly incomplete and sometimes contradictory based on methods used. Expert opinion: There is no ideal species to use in toxicology. The use of dogs and NHP in xenobiotic testing continues to be the norm. Pigs present a viable and perhaps more reliable model of non-rodent testing.
引用
收藏
页码:127 / 139
页数:13
相关论文
共 50 条
  • [21] 3-D Models in Predictive Toxicology Testing
    Aardema, M. J.
    Roy, S.
    Pfuhler, S.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2012, 53 : S16 - S16
  • [22] ANIMAL TOXICOLOGY
    KIMBROUGH, R
    BUCKLEY, J
    FISHBEIN, L
    FLAMM, G
    KASZA, L
    MARCUS, W
    SHIBKO, S
    TESKE, R
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1978, 24 (JUN) : 173 - 184
  • [25] Transgenic Animal Models in Toxicology: Historical Perspectives and Future Outlook
    Boverhof, Darrell R.
    Chamberlain, Mark P.
    Elcombe, Clifford R.
    Gonzalez, Frank J.
    Heflich, Robert H.
    Hernandez, Lya G.
    Jacobs, Abigail C.
    Jacobson-Kram, David
    Luijten, Mirjam
    Maggi, Adriana
    Manjanatha, Mugimane G.
    van Benthem, Jan
    Gollapudi, B. Bhaskar
    TOXICOLOGICAL SCIENCES, 2011, 121 (02) : 207 - 233
  • [26] Exercising animal models in inhalation toxicology: interactions with ozone and formaldehyde
    Mautz, WJ
    ENVIRONMENTAL RESEARCH, 2003, 92 (01) : 14 - 26
  • [27] Transgenic animal models for mutagenesis studies: Role in mutagenesis research and regulatory testing
    MacGregor, JT
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 1998, 32 (02) : 106 - 109
  • [28] Genetically engineered pigs as donors of pancreatic islets and as large animal models for testing the functionality of transplanted islets
    Wolf, Eckhard
    Wuensch, Annegret
    Baehr, Andrea
    Kessler, Barbara
    Renner, Simone
    van Buerck-Wolf, Lelia
    Seissler, Jochen
    Klymiuk, Nikolai
    XENOTRANSPLANTATION, 2014, 21 (06) : 591 - 591
  • [29] Introduction to the session: Organs on a chip in Toxicology - Is the end of animal testing near?
    Roth, A.
    TOXICOLOGY LETTERS, 2018, 295 : S15 - S15
  • [30] BMBF-Project funding on innovative toxicology for alternatives to animal testing
    Matthiesen, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 : S8 - S8